- Home
- KRRO vs HEQ Comparison
KRRO vs HEQ Comparison
Compare KRRO & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- HEQ
- Stock Information
- Founded
- KRRO 2014
- HEQ 2011
- Country
- KRRO United States
- HEQ United States
- Employees
- KRRO N/A
- HEQ N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- HEQ Investment Managers
- Sector
- KRRO Health Care
- HEQ Finance
- Exchange
- KRRO Nasdaq
- HEQ Nasdaq
- Market Cap
- KRRO 125.4M
- HEQ 127.8M
- IPO Year
- KRRO 2019
- HEQ N/A
- Fundamental
- Price
- KRRO $15.07
- HEQ $10.44
- Analyst Decision
- KRRO Strong Buy
- HEQ
- Analyst Count
- KRRO 7
- HEQ 0
- Target Price
- KRRO $85.67
- HEQ N/A
- AVG Volume (30 Days)
- KRRO 122.8K
- HEQ 43.1K
- Earning Date
- KRRO 08-12-2025
- HEQ 01-01-0001
- Dividend Yield
- KRRO N/A
- HEQ 9.78%
- EPS Growth
- KRRO N/A
- HEQ N/A
- EPS
- KRRO N/A
- HEQ N/A
- Revenue
- KRRO $4,821,000.00
- HEQ N/A
- Revenue This Year
- KRRO $65.08
- HEQ N/A
- Revenue Next Year
- KRRO N/A
- HEQ N/A
- P/E Ratio
- KRRO N/A
- HEQ N/A
- Revenue Growth
- KRRO N/A
- HEQ N/A
- 52 Week Low
- KRRO $10.29
- HEQ $9.08
- 52 Week High
- KRRO $98.00
- HEQ $11.84
- Technical
- Relative Strength Index (RSI)
- KRRO 48.70
- HEQ 37.41
- Support Level
- KRRO $13.34
- HEQ $10.45
- Resistance Level
- KRRO $16.77
- HEQ $10.68
- Average True Range (ATR)
- KRRO 1.46
- HEQ 0.07
- MACD
- KRRO -0.05
- HEQ -0.02
- Stochastic Oscillator
- KRRO 28.68
- HEQ 6.25
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.